Clinical Study
The Effects of Continuous Blood Purification for SIRS/MODS Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
| Study or subgroup | CVVH | Control | | Std. mean difference | Std. mean difference | Mean | SD | Total | Mean | SD | Total | Weight | IV, random, 95%CI | IV, random, 95%CI |
| 2.1.1 after 3 days
| | | | | | | | | | Liu et al. 2003 [10] | −0.4 | 1.32 | 24 | 0.4 | 1.91 | 26 | 53.9% | −0.48 (−1.04, 0.09) | Yang et al. 2004 [11] | −24.5 | 15.15 | 22 | −3.6 | 15.95 | 15 | 46.1% | −1.32 (−2.05, −0.59) | Subtotal (95%Cl) | | | 46 | | | 41 | 100.0% | −0.87 (−1.69, −0.04) | Heterogeneity: Tau2 = 0.25; Chi-square = 3.23, df = 1 ( = 0.07); = 69% | | | | | | | | | Test for overall effect = 2.05 ( = 0.04) | | | | | | | | | 2.1.2 after 7 days
| | | | | | | | | Liu et al. 2003 [10] |
−0.8
|
1.41
|
24
|
0.8
|
2.08
|
26
| 50.5% | −0.88 (−1.46, −0.30) | Zhang et al. 2008 [15] |
−46.7
|
15.05
|
30
|
−16.3
|
15.36
|
30
| 49.5% | −1.97 (−2.60, −1.35) | Subtotal (95%Cl) | | | 54 | | | 56 | 100.0% | −1.42 (−2.49, −0.35) | Heterogeneity: Tau2 = 0.50; Chi-square = 6.30, df = 1 ( = 0.01); = 84% | | | | | | | | | Test for overall effect: = 2.60 ( = 0.009) | | | | | | | | | Test for subgroup differences: Chi-square = 0.65, df = 1 ( = 0.42), = 0% | | | | | | | | |
|
|